Stephen Thomas
Directeur/Membre du Conseil chez ELIEM THERAPEUTICS, INC.
Fortune : 801 123 $ au 31/05/2024
Postes actifs de Stephen Thomas
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ELIEM THERAPEUTICS, INC. | Directeur/Membre du Conseil | 27/06/2024 | - |
Ichorion Therapeutics, Inc.
 Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Fondateur | 07/07/2017 | - |
Historique de carrière de Stephen Thomas
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Founder | 1 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELIEM THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Ichorion Therapeutics, Inc.
Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Health Technology |
- Bourse
- Insiders
- Stephen Thomas
- Expérience
